Table 3.
Summary of research results.
| The research project | -OR/MD | 95% CI | P |
|---|---|---|---|
| Total operative time | 17.43 | [-5.06,39.91] | 0.13 |
| Amount of blood loss | -82.56 | [-145.04 ,-20.08] | 0.01 |
| Transfusion rate | 0.77 | [0.53 ,1.13] | 0.18 |
| Hospital stay | -0.66 | [-2.07 , 0.76] | 0.36 |
| Days to oral intake | -0.43 | [-1.33 , 0.48] | 0.35 |
| Days to regular diet | 0.17 | [-0.22 , 0.55] | 0.40 |
| Mean lymph-node yield | 1.40 | [-0.70 , 3.50] | 0.19 |
| Positive lymph nodes | 0.89 | [0.57, 1.39] | 0.61 |
| Positive surgical margins | 1.23 | [0.69 ,2.19] | 0.49 |
| Cancer-related mortality | 0.75 | [0.17 , 3.38] | 0.71 |
| Intraoperative complications | 0.64 | [0.32, 1.30] | 0.22 |
| Grade ≤ II within 30d | 0.95 | [0.68 , 1.34] | 0.79 |
| Grade ≥ III within 30d | 0.95 | [0.60 , 1.47] | 0.8 |
| Early complications within 30d | 0.85 | [0.41 ,1.76] | 0.66 |
| Grade ≤ II postoperative ≥ 90d | 0.63 | [0.48 , 0.82] | 0.0008 |
| Grade ≥ III postoperative ≥ 90d | 0.59 | [0.40 , 0.86] | 0.006 |
| Overall complication rate | 0.52 | [0.32, 0.85] | 0.01 |